Katie Baker, DrPH, MPH, East Tennessee State University

Survey data provide evidence that US patients report interest in self-administration of DMPA-SC, with current DMPA users exhibiting greater interest than past- or never-users. Feasibility studies show family planning patients, including adolescents, can successfully self-inject DMPA-SC after being trained and that self-injecting patients report similar levels of satisfaction to patients receiving provider-administered injections. Given this ...Read more >

Nancy Fang, MD, MS, University of Colorado, Denver

Recommendations regarding contraceptive counseling and reproductive health differ amongst transgender and gender diverse (TGD) youth compared to cis-gender youth. TGD youth face unique health disparities including increased risk of sexually transmitted infections, sexual abuse and violence, and unwanted pregnancies. TGD youth also face inequities within the healthcare system including lack of access to providers and ...Read more >

Jennifer Karlin, MD, PhD, University of California, Davis

While subcutaneous depot medroxyprogesterone acetate (DMPA-SC) was designed for self-administration, the FDA approved it in the US for provider administration and insurance often covers only the clinic-administered intramuscular (IM) formulation. Despite evidence about patients’ interest in, as well as the efficacy of, DMPA-SC for user-administration, it remains an under-utilized contraceptive option for reasons hypothesized to ...Read more >

Erin Rockwell, MPH, Plan A Health, Inc.

Plan A Health is a mobile clinic providing reproductive healthcare and primary care screenings in the Mississippi Delta. With this project, we intend to assess the acceptability and feasibility of self-administered DPMA-SC as a primary form of contraception for patients in underserved rural communities. Family planning counseling on the clinic will include information on both ...Read more >

Ashley Turner, MD, MSCI, Northwestern University

DMPA is available in both subcutaneous (DMPA-SC) and intramuscular (DMPA-IM) formulations. While DMPA-SC is only FDA-approved for provider-administration, the 2021 CDC Selected Practice Recommendations advised that DMPA-SC be made available for self-administration. Multiple prior studies have compared self-administered DMPA-SC to both provider-administered DMPA-SC and DMPA-IM and found that continuation rates for self-administered DMPA-SC are higher. ...Read more >

Emily Freeman, DO, MA, MS, Washington University

The COVID-19 pandemic created a unique opportunity to develop strategies to ensure provision of reproductive health services. Telehealth can expand access to care; however, information about the patient experience with telehealth, including mode of technology is limited. Exploring patient satisfaction with contraceptive counseling delivered via two modes of telehealth can provide data that may strengthen ...Read more >

Courtney Kerestes, MD, MSCTR, The Ohio State University

Provision of contraceptive care through telemedicine offers safety advantages during a pandemic by limiting in person contact with the healthcare system. Telemedicine also has the potential to provide a convenient, private way for patients to receive evidence based contraceptive counseling based on the principles of shared decision making. If access to the internet and proper ...Read more >

Marielle Meurice, MD, University of California San Diego

The COVID-19 pandemic rapidly increased the use of telemedicine in healthcare, including contraception care. Little is known about the implications of using a telemedicine platform for equity and person-centeredness of care. We propose a sequential mixed-method study that seeks to understand the experience of contraception counseling through telemedicine for patients who speak Spanish at Planned ...Read more >

Sara Neill, MD, MPH, Beth Israel Deaconess Medical Center

The use of telehealth has rapidly expanded during the COVID-19 pandemic; due to its expeditious implementation, systems designed for in-person care are currently being used to deliver telehealth care. In-person visits for contraception decreased during the COVID-19 pandemic. Telehealth contraceptive care offers many advantages for patients, including the ability to remain in a familiar environment, ...Read more >

Bianca Stifani, MD, MPH, Westchester Medical Center

During the COVID-19 pandemic, the popularity of telemedicine rapidly increased, raising questions about its future potential to reshape the way people access healthcare, including reproductive healthcare. However, individuals with language barriers and limited access to technology may not be benefiting as much as others from the expansion of telemedicine. We propose a community engagement project ...Read more >

1 2 3 43